Whether you’re an investor, a potential partner, or a researcher who wants to learn more about the platform, we’d like to hear from you.
ViCardia Therapeutics, Inc. 530 Bush Street, Suite 802 San Francisco, CA 94108
A clinical-stage biopharmaceutical company developing MitoForge™, a precision intracellular delivery platform for mitochondrial metabolic dysfunction.
© 2026 ViCardia Therapeutics, Inc. All Rights Reserved.
MitoForge™ and Precision Intracellular Delivery™ are trademarks of ViCardia Therapeutics, Inc.